Chenghong Pharmaceutical (Weihai) Limited Liability Company

Chenghong Pharmaceutical (Weihai) Limited Liability Company

Chenghong Pharmaceutical (Weihai) Limited Liability Company was established in September 2020 with a registered capital of 30.64 million yuan, located at Zhuhai Road, Economic Development Zone, Wendeng District, Weihai City, Shandong Province. The company is committed to the research and development, production and globalization sales of innovative drugs, distinctive generic APIs and advanced intermediates, and undertakes the custom manufacturing (CMO) and custom research and development manufacturing (CDMO) business of APIs of innovative drugs by international standards, promotes the globalization of innovative drugs to market, and builds a green high-end API company facing the middle and high-end markets in Europe, the United States and Japan. 

The company has built Weihai Green Pharmaceutical Technology Key Laboratory, with a laboratory area of 1,200 square meters and a pilot plant of 3,000 square meters, equipped with nearly one hundred sets of test equipment, with 35 researchers, including 4 PhDs and 7 masters. At the same time, the company shares the investor Fonda Pharma's 130,000 square meters of laboratory facilities in 7 cities in China and the United States and 1,322 high-end talents covering the whole process of pharmaceutical R&D.